ACER

Q: What is the price of Acer Therapeutics (ACER) today?

A cotação de Acer Therapeutics (ACER) hoje está em $ 0.00, com uma variação de The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. negociando na casa dos $ 0.00 e hoje está em $ 0.00. Acompanhe o and track broader market trends directly on the platform.

Q: When does Acer Therapeutics (ACER) pay dividends?

Acer Therapeutics (ACER) did not pay dividends over the past year.

Q: Is Acer Therapeutics (ACER) a good investment?

Atualmente, Acer Therapeutics (ACER) está cotada a $ 0.00, com um P/L de -0.31, This represents a -68% premium compared to its historical average P/E. uma variação de 0 em sua cotação e distribuiu $ 0.00 em dividendos, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Acer Therapeutics Inc.

Price

$ -

return (12m)

0.00%

p/e

-0.31

p/bv

-0.48

DIVIDEND YIELD

0.00%

ACER price

ACER

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment ACER

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals ACER

review the fundamentals of Acer Therapeutics shares

P/E

-0.31

Sector: -236.86 Industry: -54.29

P/S (PSR)

Sector: 1.41 Industry: 1.63

P/BV

-0.48

Sector: 0.44 Industry: 0.46

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-345.45%

Sector: -172.33% Industry: -284.85%

ROE

152.20%

Sector: -398.12% Industry: -498.69%

ROIC

-42.39%

Sector: -428.36% Industry: -81.70%

NET MARGIN

0.00%

Sector: -51.44% Industry: -59.90%

GROSS MARGIN

0.00%

Sector: 27.46% Industry: 30.13%

OPERATING MARGIN

0.00%

Sector: -47.58% Industry: -58.80%

EV/EBITDA

-0.68

Sector: -221.25 Industry: -48.87

EV/EBIT

-0.68

Sector: -229.16 Industry: -49.62

PRICE-TO-ASSETS

1.08

Sector: 0.72 Industry: 0.67

BVPS

-1.39

Sector: -2.82 Industry: 0.60

EPS

-2.11

Sector: -9,587.37 Industry: -6.92

EQUITY-TO-ASSETS RATIO

-2.27

Sector: -0.01 Industry: -0.18

LIABILITIES / ASSETS

-2.27

Sector: 0.30 Industry: 0.37

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

32.41%

Sector: - Industry: -

Fundamentals ACER

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	33.59	27.21	81.01%	0.66%	$ 848.86 B	34.98%
ISRG	53.63	9.08	16.93%	0.00%	$ 159.77 B	28.15%
TMO	25.26	3.32	13.15%	0.38%	$ 172.98 B	15.15%
SNY	11.59	1.26	10.86%	5.11%	$ 105.72 B	18.68%
NVS	20.60	7.16	34.77%	2.12%	$ 278.77 B	23.92%
ABT	25.14	0.00	0.00%	2.64%	$ 157.79 B	13.91%
MDT	21.18	1.99	9.38%	3.73%	$ 97.70 B	13.00%
GSK	12.93	4.37	33.77%	3.48%	$ 101.42 B	17.79%
CVS	39.31	1.48	3.78%	2.94%	$ 115.27 B	0.72%
BSX	22.46	0.00	0.00%	0.00%	$ 80.09 B	17.29%
TMDX	13.42	4.67	34.80%	0.00%	$ 2.31 B	27.04%
HCA	14.35	-32.73	-228.14%	0.68%	$ 97.48 B	8.89%
IDXX	40.91	28.80	70.38%	0.00%	$ 44.81 B	24.63%
RMD	19.73	4.62	23.41%	1.13%	$ 29.98 B	27.44%
DHR	32.85	2.29	6.97%	0.79%	$ 121.18 B	14.89%
INMD	10.09	1.33	13.18%	0.00%	$ 879.48 M	23.27%
PHG	22.93	1.96	8.56%	3.26%	$ 25.90 B	5.50%
SYK	32.76	4.76	14.52%	1.21%	$ 109.34 B	13.21%
FMS	11.00	0.74	6.71%	3.57%	$ 12.12 B	4.89%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

ACER Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Acer Therapeutics

Acer Therapeutics Inc.

Average Investor10 user rating

4.0 (1 people)

United States

35 years

Founded: 1991

2002

Time since IPO - 24 years

20

Employees

Acer Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $15.84 Millions, with shareholders equity totaling $-33.25 Millions.

The company employs approximately 20 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Acer Therapeutics Inc. reported $- in revenue, generating net income of $-50.61 Millions.

Key financial metrics include a P/E ratio of -0.31, a price-to-book (P/B) ratio of -0.48, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ACER.

Market cap

$ 15.84 Millions

Net worth

$ -33.25 Millions

$ -33,250,000.00

Assets

$ 14.65 Millions

$ 14,650,000.00

Total Shares Outstanding

24.00 Millions

24,000,000

Average Daily Trading Volume

$ 179.37 Thousand

$ 179,366.12

Sector

Health

Industry

Pharmaceutical Products

ACER

ACER revenue and profits

Financial Results ACER

DRAG THE FRAME TO SEE MORE DATA

ACER cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 90.55 40,16% (12M)

P/E

39.31

2.94%

ROE

3.78%

P/BV

1.48

CI - Cigna

$ 288.06 --11,31% (12M)

P/E

10.52

2.11%

ROE

16.97%

P/BV

1.79

CNC - Centene

$ 55.96 --10,88% (12M)

P/E

-4.27

0.00%

ROE

-29.93%

P/BV

1.28

HUM - Humana

$ 274.96 12,29% (12M)

P/E

29.20

1.29%

ROE

6.06%

P/BV

1.77

LLY - Eli Lilly

$ 948.45 26,67% (12M)

P/E

33.59

0.66%

ROE

81.01%

P/BV

27.21

HCA - HCA Healthcare

$ 435.19 24,09% (12M)

P/E

14.35

0.68%

ROE

-228.14%

P/BV

-32.73

NVS - Novartis

$ 146.03 36,97% (12M)

P/E

20.60

2.12%

ROE

34.77%

P/BV

7.16